Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 20113460)

Published in Value Health on January 26, 2010

Authors

Karen Pendergast1, Anne Wolf, Beth Sherrill, Xiaolei Zhou, Louis J Aronne, Ian Caterson, Nicholas Finer, Hans Hauner, James Hill, Luc Van Gaal, Florence Coste, Jean-Pierre Despres

Author Affiliations

1: RTI Health Solutions, Research Triangle Park, NC, USA.

Articles by these authors

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA (2006) 9.04

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet (2009) 7.24

FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med (2015) 6.48

T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol (2008) 5.44

Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet (2011) 4.99

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. Lancet (2010) 4.89

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72

Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med (2006) 3.77

Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab (2006) 3.72

Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav (2008) 3.52

The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain (2010) 3.51

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41

A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med (2002) 3.04

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01

Dynamics of human adipose lipid turnover in health and metabolic disease. Nature (2011) 2.90

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (2013) 2.84

Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 2.71

Outcome of percutaneous rupture of lumbar synovial cysts: a case series of 101 patients. Spine J (2009) 2.62

Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J (2007) 2.56

The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents. Sleep Med Rev (2008) 2.33

Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care (2006) 2.18

The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis. J Biol Chem (2002) 2.17

Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism (2006) 2.14

Gestational weight gain and long-term postpartum weight retention: a meta-analysis. Am J Clin Nutr (2011) 2.06

Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2015) 2.05

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia. Arterioscler Thromb Vasc Biol (2010) 2.03

Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology (2004) 2.00

Zonisamide for weight reduction in obese adults. JAMA (2013) 2.00

Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev (2012) 1.96

Adipose and height growth through childhood and blood pressure status in a large prospective cohort study. Hypertension (2012) 1.89

Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum (2003) 1.84

Variants in the FTO gene are associated with common obesity in the Belgian population. Mol Genet Metab (2007) 1.82

Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. Eur Heart J (2010) 1.73

Childhood obesity and vascular phenotypes: a population study. J Am Coll Cardiol (2012) 1.72

Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas (2007) 1.69

Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child (2006) 1.67

Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax (2007) 1.62

Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem (2003) 1.62

Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies. Obes Rev (2005) 1.62

The dynamic range of the human metabolome revealed by challenges. FASEB J (2012) 1.61

Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med (2006) 1.60

Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace (2010) 1.59

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation (2004) 1.56

Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes (2009) 1.54

C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol (2011) 1.54

Precise microinjection into skin using hollow microneedles. J Invest Dermatol (2006) 1.51

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. Am J Respir Crit Care Med (2015) 1.47

The prevention and treatment of obesity. Dtsch Arztebl Int (2014) 1.44

Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial. Diabetes Care (2013) 1.41

Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur J Nutr (2009) 1.40

The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods. Addiction (2006) 1.38

Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism (2004) 1.38

Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts (2008) 1.37

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial. Diabetes Care (2002) 1.35

Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.31

Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma (2010) 1.30

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res (2012) 1.28

Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes (2002) 1.27

Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation (2011) 1.27

Translating research for evidence-based public health: key concepts and future directions. J Epidemiol Community Health (2012) 1.26

The impact of a health professional recommendation on weight loss attempts in overweight and obese British adults: a cross-sectional analysis. BMJ Open (2013) 1.25

Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich) (2012) 1.23

Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring) (2012) 1.23

A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1. Hum Genet (2006) 1.22

The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One (2013) 1.22

Risk factors associated with prolonged recovery and delayed healing after third molar surgery. J Oral Maxillofac Surg (2003) 1.21

Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J Biol Chem (2001) 1.20

Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) (2010) 1.19

Cancer risk in Lynch Syndrome. Fam Cancer (2013) 1.19

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol (2009) 1.19

Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes (2008) 1.15

Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2008) 1.14

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res (2007) 1.14

Effect of long-term whole body vibration training on visceral adipose tissue: a preliminary report. Obes Facts (2010) 1.14

Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. Am J Cardiol (2005) 1.13

Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care (2011) 1.12

Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab (2011) 1.12

Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes (2011) 1.12

A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States. Adv Urol (2011) 1.11

The metabolic profile of early Huntington's disease--a combined human and transgenic mouse study. Exp Neurol (2008) 1.11

The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol (2005) 1.11

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity. Circulation (2004) 1.10

FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias. Eur J Hum Genet (2007) 1.09

Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol (2004) 1.09

Monitoring of posture allocations and activities by a shoe-based wearable sensor. IEEE Trans Biomed Eng (2010) 1.09

Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg (2007) 1.08

Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. Hand (N Y) (2010) 1.07

Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics (2002) 1.06

Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany. Dtsch Arztebl Int (2008) 1.06

Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks. Diabetes Care (2012) 1.04

Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med (2005) 1.04

Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg (2014) 1.04

Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol (2006) 1.02

The T111I mutation in the EL gene modulates the impact of dietary fat on the HDL profile in women. J Lipid Res (2003) 1.02

Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res (2003) 1.01

Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care (2007) 1.01

Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res (2004) 1.00